Jounce Therapeutics Inc (JNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,463 | 74,991 | 53,241 | 66,402 | 37,994 |
| Marketable Securities | 52,742 | 71,975 | 115,602 | 109,398 | 114,026 |
| TOTAL | $131,311 | $152,359 | $173,697 | $181,053 | $157,348 |
| Non-Current Assets | |||||
| PPE Net | 8,898 | 9,755 | 10,672 | 11,588 | 12,148 |
| Investments And Advances | 0 | 1,608 | 1,601 | 9,297 | 0 |
| Other Non-Current Assets | 18,692 | 19,228 | 19,912 | 20,420 | 21,108 |
| TOTAL | $27,590 | $30,591 | $32,185 | $41,305 | $33,256 |
| Total Assets | $158,901 | $182,950 | $205,882 | $222,358 | $190,604 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,034 | 3,722 | 2,460 | 3,408 | 2,596 |
| Accrued Expenses | 10,167 | 7,543 | 8,907 | 7,032 | 7,344 |
| Other current liabilities | 53 | 39 | 132 | 54 | 47 |
| TOTAL | $16,336 | $14,295 | $14,400 | $13,308 | $77,595 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 64,879 |
| Other Non-Current Liabilities | 15,296 | 16,111 | 16,889 | 17,641 | 18,379 |
| TOTAL | $15,296 | $16,111 | $16,889 | $17,641 | $22,945 |
| Total Liabilities | $31,632 | $30,406 | $31,289 | $30,949 | $100,540 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,068 | 34,053 | 34,049 | 33,229 | 32,982 |
| Common Shares | 34 | 34 | 34 | 33 | 33 |
| Retained earnings | -161,570 | -133,602 | -107,159 | -84,492 | -183,352 |
| Other shareholders' equity | 133 | 144 | 54 | 78 | 135 |
| TOTAL | $127,269 | $152,544 | $174,593 | $191,409 | $90,064 |
| Total Liabilities And Equity | $158,901 | $182,950 | $205,882 | $222,358 | $190,604 |